Morgan Stanley’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.72M | Sell |
155,484
-145,107
| -48% | -$2.88M | ﹤0.01% | 4544 |
|
|
2025
Q4 | $5.9M | Sell |
300,591
-26,502
| -8% | -$550K | ﹤0.01% | 4055 |
|
|
2025
Q3 | $9.01M | Sell |
327,093
-2,520
| -0.8% | -$77.5K | ﹤0.01% | 3638 |
|
|
2025
Q2 | $10.1M | Buy |
329,613
+30,694
| +10% | +$872K | ﹤0.01% | 3436 |
|
|
2025
Q1 | $8.06M | Buy |
298,919
+91,182
| +44% | +$2.89M | ﹤0.01% | 3537 |
|
|
2024
Q4 | $7.46M | Sell |
207,737
-10,365
| -5% | -$388K | ﹤0.01% | 3645 |
|
|
2024
Q3 | $8.27M | Buy |
218,102
+1,195
| +0.6% | +$49.1K | ﹤0.01% | 3575 |
|
|
2024
Q2 | $9.81M | Sell |
216,907
-23,140
| -10% | -$1.06M | ﹤0.01% | 3343 |
|
|
2024
Q1 | $11.6M | Sell |
240,047
-262,943
| -52% | -$12.9M | ﹤0.01% | 3219 |
|
|
2023
Q4 | $27M | Buy |
502,990
+229,126
| +84% | +$11.6M | ﹤0.01% | 3083 |
|
|
2023
Q3 | $16.1M | Buy |
273,864
+69,085
| +34% | +$4.32M | ﹤0.01% | 2684 |
|
|
2023
Q2 | $12.9M | Sell |
204,779
-7,397
| -3% | -$471K | ﹤0.01% | 2921 |
|
|
2023
Q1 | $13.3M | Buy |
212,176
+22,924
| +12% | +$1.37M | ﹤0.01% | 2868 |
|
|
2022
Q4 | $10.1M | Buy |
189,252
+47,482
| +33% | +$2.57M | ﹤0.01% | 3091 |
|
|
2022
Q3 | $7.95M | Sell |
141,770
-14,282
| -9% | -$944K | ﹤0.01% | 3202 |
|
|
2022
Q2 | $11.3M | Buy |
156,052
+64,357
| +70% | +$4.79M | ﹤0.01% | 2948 |
|
|
2022
Q1 | $7.29M | Buy |
91,695
+7,564
| +9% | +$682K | ﹤0.01% | 3276 |
|
|
2021
Q4 | $8.51M | Buy |
84,131
+17,550
| +26% | +$1.75M | ﹤0.01% | 3121 |
|
|
2021
Q3 | $6.14M | Sell |
66,581
-12,908
| -16% | -$1.24M | ﹤0.01% | 3460 |
|
|
2021
Q2 | $8.14M | Sell |
79,489
-14,594
| -16% | -$1.47M | ﹤0.01% | 3234 |
|
|
2021
Q1 | $9.18M | Sell |
94,083
-27,127
| -22% | -$2.47M | ﹤0.01% | 2747 |
|
|
2020
Q4 | $9.35M | Buy |
121,210
+74,969
| +162% | +$5.8M | ﹤0.01% | 2583 |
|
|
2020
Q3 | $3.4M | Sell |
46,241
-48,698
| -51% | -$3.91M | ﹤0.01% | 3108 |
|
|
2020
Q2 | $6.97M | Sell |
94,939
-124,996
| -57% | -$9.8M | ﹤0.01% | 2320 |
|
|
2020
Q1 | $12.7M | Buy |
219,935
+46,390
| +27% | +$3.23M | ﹤0.01% | 1597 |
|
|
2019
Q4 | $13.6M | Buy |
173,545
+76,053
| +78% | +$5.6M | ﹤0.01% | 2059 |
|
|
2019
Q3 | $6.67M | Sell |
97,492
-199,762
| -67% | -$13.4M | ﹤0.01% | 2561 |
|
|
2019
Q2 | $23.6M | Buy |
297,254
+773
| +0.3% | +$61.3K | 0.01% | 1362 |
|
|
2019
Q1 | $24.9M | Buy |
296,481
+270,241
| +1,030% | +$28.2M | 0.01% | 1297 |
|
|
2018
Q4 | $3.09M | Sell |
26,240
-25,731
| -50% | -$2.98M | ﹤0.01% | 3405 |
|
|
2018
Q3 | $6.26M | Sell |
51,971
-72,304
| -58% | -$8.97M | ﹤0.01% | 2939 |
|
|
2018
Q2 | $14.3M | Sell |
124,275
-713
| -0.6% | -$78K | ﹤0.01% | 1978 |
|
|
2018
Q1 | $10.7M | Buy |
124,988
+48,254
| +63% | +$3.74M | ﹤0.01% | 2276 |
|
|
2017
Q4 | $5.68M | Buy |
76,734
+20,888
| +37% | +$1.4M | ﹤0.01% | 2976 |
|
|
2017
Q3 | $3.22M | Sell |
55,846
-84,054
| -60% | -$4.97M | ﹤0.01% | 3414 |
|
|
2017
Q2 | $8.97M | Sell |
139,900
-62,969
| -31% | -$3.88M | ﹤0.01% | 2279 |
|
|
2017
Q1 | $11.7M | Buy |
202,869
+3,003
| +2% | +$179K | ﹤0.01% | 2051 |
|
|
2016
Q4 | $12.2M | Buy |
199,866
+19,962
| +11% | +$1.3M | ﹤0.01% | 2034 |
|
|
2016
Q3 | $12.4M | Sell |
179,904
-89,174
| -33% | -$5.88M | ﹤0.01% | 1829 |
|
|
2016
Q2 | $15M | Sell |
269,078
-2,422
| -0.9% | -$146K | 0.01% | 1652 |
|
|
2016
Q1 | $16.5M | Buy |
271,500
+57,218
| +27% | +$3.37M | 0.01% | 1457 |
|
|
2015
Q4 | $13.7M | Sell |
214,282
-51,948
| -20% | -$3.37M | 0.01% | 1721 |
|
|
2015
Q3 | $17.8M | Buy |
266,230
+138,634
| +109% | +$9.8M | 0.01% | 1472 |
|
|
2015
Q2 | $8.72M | Sell |
127,596
-19,202
| -13% | -$1.22M | ﹤0.01% | 2236 |
|
|
2015
Q1 | $8.16M | Sell |
146,798
-99,750
| -40% | -$5.11M | ﹤0.01% | 2279 |
|
|
2014
Q4 | $12.6M | Buy |
246,548
+90,426
| +58% | +$4.44M | ﹤0.01% | 1850 |
|
|
2014
Q3 | $5.75M | Buy |
156,122
+770
| +0.5% | +$27.8K | ﹤0.01% | 2526 |
|
|
2014
Q2 | $6.07M | Sell |
155,352
-80,882
| -34% | -$3M | ﹤0.01% | 2487 |
|
|
2014
Q1 | $8.9M | Buy |
236,234
+78,952
| +50% | +$2.76M | ﹤0.01% | 2053 |
|
|
2013
Q4 | $5.94M | Sell |
157,282
-11,698
| -7% | -$448K | ﹤0.01% | 2419 |
|
|
2013
Q3 | $7.33M | Buy |
168,980
+39,594
| +31% | +$1.59M | ﹤0.01% | 2065 |
|
|
2013
Q2 | $4.68M | Buy |
+129,386
| New | +$3.93M | ﹤0.01% | 2390 |
|
Other funds holding USNA
NCM
VCM
VPM
Morgan Stanley's USNA Position: Q1 2026 in Review
Morgan Stanley reduced its Usana Health Sciences (USNA) stake by 48% in Q1 2026, selling an estimated $2.88M and leaving 155,484 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #4544.
Morgan Stanley first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q4 2023. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Morgan Stanley held 155,484 shares of Usana Health Sciences worth $2.72M as of Q1 2026.
- Morgan Stanley sold 145,107 Usana Health Sciences shares in Q1 2026, an estimated $2.88M.
- Usana Health Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4544 holding.
- Morgan Stanley first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Usana Health Sciences position peaked at $27M in Q4 2023.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.